Celesia BM, Marino A, Fontana del Vecchio R, Bruno R, Palermo F, Gussio M, Nunnari G, Cacopardo B. IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/┬ÁL?. Mediterr J Hematol Infect Dis [Internet]. 2019 Oct. 30 [cited 2022 Sep. 25];11(1):e2019063. Available from: https://mjhid.org/index.php/mjhid/article/view/2019.063